Related Experiment Videos
Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex
1Department of Neurology, Stanford University Medical Center, CA 94305.
Neuroscience Letters
|December 19, 1988
Summary
Three amphetamine derivatives, including MDMA (Ecstasy), show high affinity for the DOB binding site. MDA also binds to serotonin and adrenergic sites, potentially explaining their psychoactive effects.
Area of Science:
- Neuroscience
- Pharmacology
- Medicinal Chemistry
Background:
- Ring-substituted amphetamines like MDMA (Ecstasy) possess unique psychoactive properties.
- Understanding their molecular interactions is crucial for elucidating their effects.
Purpose of the Study:
- To determine the binding affinities of three ring-substituted amphetamines at various neurotransmitter binding sites in the human cortex.
- To correlate these binding profiles with the known psychoactive effects of these compounds.
Main Methods:
- Radioligand binding assays were performed using human cortical tissue.
- The affinities of MDA, MDE, and MDMA were measured at nine different neurotransmitter receptors.
Main Results:
- MDA, MDE, and MDMA exhibited highest affinity (approximately 1 microM) for the DOB binding site.
- MDA also showed moderate affinity (4-5 microM) for 5-HT1A, 5-HT1D, and alpha 2-adrenergic sites.
- MDE and MDMA had low affinity or were inactive at other tested sites.
Conclusions:
- The high affinity for the DOB binding site is a common characteristic of these ring-substituted amphetamines.
- MDA's additional interactions with serotonin and adrenergic receptors may contribute to its distinct pharmacological profile.
- These findings provide insights into the neurochemical basis of the psychoactive effects of these amphetamine derivatives.